PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,161 | -25.5% | 19,453 | 0.0% | 0.00% | – |
| Q2 2023 | $68,669 | +14.2% | 19,453 | 0.0% | 0.00% | – |
| Q1 2023 | $60,110 | -26.9% | 19,453 | 0.0% | 0.00% | – |
| Q4 2022 | $82,286 | -0.9% | 19,453 | -32.5% | 0.00% | – |
| Q2 2022 | $83,000 | -61.6% | 28,820 | -61.6% | 0.00% | – |
| Q1 2022 | $216,000 | -12.2% | 74,994 | -7.0% | 0.00% | – |
| Q4 2021 | $246,000 | -56.5% | 80,652 | 0.0% | 0.00% | – |
| Q3 2021 | $566,000 | -78.0% | 80,652 | -71.2% | 0.00% | -100.0% |
| Q2 2021 | $2,568,000 | -1.4% | 279,675 | +4.4% | 0.00% | 0.0% |
| Q1 2021 | $2,605,000 | -22.6% | 267,956 | -18.3% | 0.00% | 0.0% |
| Q4 2020 | $3,366,000 | +3.5% | 327,976 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $3,252,000 | -3.3% | 322,245 | -0.1% | 0.00% | -50.0% |
| Q2 2020 | $3,364,000 | +28.6% | 322,497 | +4.1% | 0.00% | 0.0% |
| Q1 2020 | $2,615,000 | -11.5% | 309,762 | -8.3% | 0.00% | 0.0% |
| Q4 2019 | $2,956,000 | -21.3% | 337,789 | -3.2% | 0.00% | 0.0% |
| Q3 2019 | $3,756,000 | +62.8% | 348,838 | +92.2% | 0.00% | +100.0% |
| Q2 2019 | $2,307,000 | -65.9% | 181,507 | +4.1% | 0.00% | -75.0% |
| Q1 2019 | $6,761,000 | +105.4% | 174,291 | +7.8% | 0.00% | +33.3% |
| Q4 2018 | $3,291,000 | -56.1% | 161,711 | -1.1% | 0.00% | -40.0% |
| Q3 2018 | $7,499,000 | -21.0% | 163,544 | +2.0% | 0.01% | -28.6% |
| Q2 2018 | $9,488,000 | -7.4% | 160,394 | +6.5% | 0.01% | -12.5% |
| Q1 2018 | $10,248,000 | -26.1% | 150,581 | +7.4% | 0.01% | -27.3% |
| Q4 2017 | $13,859,000 | -14.4% | 140,198 | +3.7% | 0.01% | -21.4% |
| Q3 2017 | $16,187,000 | +50.1% | 135,167 | +9.6% | 0.01% | +40.0% |
| Q2 2017 | $10,784,000 | +142.9% | 123,380 | +3.4% | 0.01% | +150.0% |
| Q1 2017 | $4,439,000 | +27.7% | 119,312 | +5.4% | 0.00% | 0.0% |
| Q4 2016 | $3,475,000 | -43.4% | 113,174 | +23.7% | 0.00% | -42.9% |
| Q3 2016 | $6,137,000 | +96.1% | 91,519 | -12.9% | 0.01% | +75.0% |
| Q2 2016 | $3,129,000 | +82.0% | 105,022 | +79.5% | 0.00% | +100.0% |
| Q1 2016 | $1,719,000 | -65.2% | 58,500 | -7.2% | 0.00% | -71.4% |
| Q4 2015 | $4,943,000 | +11.4% | 63,042 | +7.1% | 0.01% | 0.0% |
| Q3 2015 | $4,438,000 | +21.4% | 58,885 | +88.1% | 0.01% | +40.0% |
| Q2 2015 | $3,655,000 | -78.2% | 31,306 | -55.9% | 0.01% | -79.2% |
| Q1 2015 | $16,773,000 | +34.2% | 71,038 | +7.6% | 0.02% | +26.3% |
| Q4 2014 | $12,495,000 | -19.0% | 66,014 | +2.1% | 0.02% | -24.0% |
| Q3 2014 | $15,430,000 | +256.7% | 64,677 | -1.3% | 0.02% | +257.1% |
| Q2 2014 | $4,326,000 | -34.3% | 65,544 | +3.6% | 0.01% | -41.7% |
| Q1 2014 | $6,587,000 | +12.9% | 63,246 | +12.2% | 0.01% | +9.1% |
| Q4 2013 | $5,834,000 | +92.3% | 56,349 | +3.7% | 0.01% | +83.3% |
| Q3 2013 | $3,034,000 | +57.3% | 54,336 | +33.8% | 0.01% | +50.0% |
| Q2 2013 | $1,929,000 | – | 40,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |